MemorialCare Neuroscience Institute Introduces Groundbreaking Aneurysm Detection Technology in Southern California
In a significant advancement in the realm of neurological health, MemorialCare Neuroscience Institute has made headlines by becoming the first facility in Los Angeles and Orange Counties to implement the state-of-the-art Rapid Aneurysm technology. This pioneering technology is set to revolutionize how brain aneurysms are detected and monitored across Southern California.
The Rapid Aneurysm technology, developed by RapidAI, leverages artificial intelligence to analyze brain imaging scans, specifically CT angiography (CTA) and magnetic resonance angiography (MRA). This innovative system automatically scans the images for potential aneurysms, flagging any suspicious findings for further examination by expert radiologists and neuro stroke teams. Additionally, it provides intricate three-dimensional measurements of the aneurysms, essential for devising tailored monitoring and treatment plans.
Dr. Viktor Szeder, a neurointerventionalist at MemorialCare, highlights a crucial aspect of aneurysm care: the ability to assess which aneurysms necessitate treatment versus those that can be safely observed over time. The importance of early detection cannot be overstated; catching an aneurysm before it ruptures allows healthcare providers to devise a strategic management plan, significantly lowering the patient's risk of severe complications down the line.
According to reports from the Brain Aneurysm Foundation, approximately 6.8 million Americans are living with an unruptured brain aneurysm, many of whom are unaware of their condition due to the lack of noticeable symptoms. The unfortunate reality is that these aneurysms often remain undetected until they reach a crisis point – which underscores the critical need for early detection methodologies and ongoing monitoring.
Dr. Szeder elaborates on the workings of the Rapid Aneurysm technology, describing its capability to produce detailed three-dimensional models of flagged aneurysms. The technology converts standard flat images into volumetric data, allowing for a nuanced understanding of the aneurysm's size and shape over time. It offers precise monitoring of subtle changes that may indicate growth, an important factor in determining whether treatment is necessary. Notably, growth in aneurysm size correlates strongly with an increased risk of rupture.
The introduction of Rapid Aneurysm means patients will not have to undergo additional scans or appointments for this AI analysis; it is seamlessly integrated into the existing workflow for MemorialCare patients undergoing CTA or MRA. Every diagnosis made by the technology is subsequently confirmed by radiologists, ensuring accurate assessments and enabling timely connections to specialists for those diagnosed with confirmed aneurysms.
MemorialCare’s commitment to preventive health is epitomized by this advancement. Liz Acord, vice president of clinical institutes at MemorialCare, emphasizes that the integration of Rapid Aneurysm technology marks a shift from reactive to proactive healthcare. This commitment to early detection and risk assessment reflects the organization’s dedication to serving its South Bay and South Orange County communities.
Patients can access neurovascular care through MemorialCare’s Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center. The Long Beach facility is notably home to a Comprehensive Stroke Center and the Division of Interventional Neuroradiology, which has been providing minimally invasive treatment for various neurological issues for over 15 years.
In conclusion, the innovative Rapid Aneurysm technology represents a groundbreaking leap forward in the field of neurology, particularly in the ongoing battle against brain aneurysms. With early detection and precise monitoring capabilities, patients are afforded the opportunity to manage their conditions proactively, potentially averting emergency scenarios that often arise from undetected aneurysm ruptures. This initiative solidifies MemorialCare Neuroscience Institute's role as a leader in patient-centered neurological care, dedicated to advancing health outcomes across Southern California.